Pulse Biosciences initiated at Buy; Freedom Capital Markets sets $73 target
Freedom Capital Markets initiated Pulse Biosciences at Buy and announced a $73.00/share price target, (TradingView News)
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.